Related Experiment Video
Updated: Jun 19, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to
Junpeng Yan1, Qing Li, Sam Lievens
1Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Abstract:
The cellular bromodomain protein Brd4 is a major interacting partner of the papillomavirus (PV) E2 protein. Interaction of E2 with Brd4 contributes to viral episome maintenance. The E2-Brd4 interaction also plays an important role in repressing viral oncogene expression from the integrated viral genome in human PV (HPV)-positive cancer cells. However, the underlying mechanism is not clearly understood. In host cells, Brd4 recruits positive transcription elongation factor b (P-TEFb) to stimulate RNA polymerase II phosphorylation during cellular and viral gene expression. P-TEFb associates with the C terminus of Brd4, which largely overlaps with the E2 binding site on Brd4. In this study, we demonstrate that E2 binding to Brd4 inhibits the interaction of endogenous Brd4 and P-TEFb. P-TEFb is essential for viral oncogene E6/E7 transcription in both HeLa and CaSki cells that contain integrated HPV genomes. E2 binding to Brd4 abrogates the recruitment of P-TEFb to the integrated viral chromatin template, leading to inactivation of P-TEFb and repression of the viral oncogene E6/E7. Furthermore, dissociation of the Brd4-P-TEFb complex from the integrated viral chromatin template using a Brd4 bromodomain dominant-negative inhibitor also hampers HPV E6/E7 oncogene expression. Our data support that Brd4 recruitment of P-TEFb to the viral chromatin template is essential for viral oncogene expression. Abrogation of the interaction between P-TEFb and Brd4 thus provides a mechanism for E2-mediated repression of the viral oncogenes from the integrated viral genomes in cancer cells.
Insights
Human papillomavirus (HPV) E2 protein binding to Brd4 inhibits P-TEFb recruitment, repressing viral oncogene expression from integrated HPV genomes in cancer cells.
Area of Science:
- Molecular Biology
- Virology
- Cancer Biology
Background:
- Brd4, a cellular bromodomain protein, interacts with papillomavirus (PV) E2 protein, aiding viral episome maintenance and repressing oncogene expression in HPV-positive cancers.
- Brd4 recruits positive transcription elongation factor b (P-TEFb) to promote RNA polymerase II phosphorylation, crucial for gene expression.
Purpose of the Study:
- To elucidate the mechanism by which HPV E2 protein binding to Brd4 represses viral oncogene expression from integrated HPV genomes.
- To investigate the role of the Brd4-P-TEFb interaction in HPV oncogene transcription.
Main Methods:
- Investigated the interaction between E2, Brd4, and P-TEFb in HPV-positive cancer cells (HeLa and CaSki).
- Utilized a Brd4 bromodomain dominant-negative inhibitor to disrupt the Brd4-P-TEFb complex.
- Assessed the impact on viral oncogene E6/E7 transcription and recruitment of P-TEFb to viral chromatin.
Main Results:
- E2 binding to Brd4 inhibits the interaction between Brd4 and P-TEFb.
- E2 binding abrogates P-TEFb recruitment to integrated HPV chromatin, inactivating P-TEFb and repressing E6/E7 oncogene expression.
- Disruption of the Brd4-P-TEFb complex also reduces HPV E6/E7 oncogene expression.
Conclusions:
- Brd4's recruitment of P-TEFb to viral chromatin is essential for HPV oncogene expression.
- The E2-mediated abrogation of the Brd4-P-TEFb interaction provides a mechanism for repressing viral oncogenes in HPV-associated cancers.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Restarting Stalled Replication Forks
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation

